Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics Europe 2018

Victor Ugaz's Biography



Victor Ugaz, Professor & Holder of the Charles D. Holland ’53 Professorship, Artie McFerrin Department of Chemical Engineering, Texas A&M University

Upon completion of his doctoral degree in Chemical Engineering at Northwestern University (Chicago, IL, USA), Dr. Ugaz spent three years as a postdoctoral research fellow under the supervision of Prof. Mark Burns in the department of chemical engineering at the University of Michigan (Ann Arbor, MI, USA), a pioneer in the development of integrated microfluidic DNA analysis systems. Dr. Ugaz joined the faculty in the Department of Chemical Engineering at Texas A&M University (College Station, TX, USA) in January 2003 and currently holds the rank of Professor. His research interests include transport and flow in microfluidic systems, convectively driven biochemical reactions for DNA replication, microsystems for DNA analysis, and materials and processes for construction of microfluidic environments. He has published scientific articles in journals including Proceedings of the National Academies of Sciences of the USA, Advanced Materials, Angewandte Chemie, Nano Letters, Nature Communications, Science, Physical Review Letters, Lab on a Chip, Analytical Chemistry, and Electrophoresis. His research has been funded by a variety of sources including the US National Science Foundation, US National Institutes of Health, US Department of Energy, and US Department of Defense.

Victor Ugaz Image

Microfluidic Technologies in Liquid Biopsy: Needle-to-Needle Challenges

Tuesday, 5 June 2018 at 17:30

Add to Calendar ▼2018-06-05 17:30:002018-06-05 18:30:00Europe/LondonMicrofluidic Technologies in Liquid Biopsy: Needle-to-Needle ChallengesLab-on-a-Chip and Microfluidics Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Liquid biopsy techniques are revolutionizing healthcare by enabling sophisticated bioanalysis to be performed in a minimally invasive manner. And these methods have shown particular promise in the diagnosis and treatment of cancer, where screening of cellular and extracellular material makes it possible to monitor disease progression and develop personalized therapies. But existing approaches to isolate, detect, and analyze liquid biopsy samples are complex and deliver limited throughput, making them challenging to deploy as routine diagnostic tools. Therefore, we are developing a microfluidic platform that combines high-throughput isolation and label-free imaging to rapidly screen rare cell populations. I will describe these efforts and provide a broader perspective of challenges and opportunities for microfluidic technologies in the areas of liquid biopsy and personalized medicine.


Add to Calendar ▼2018-06-05 00:00:002018-06-06 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Europe 2018Lab-on-a-Chip and Microfluidics Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com